3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to initial information suggesting unique pharmacological characteristics. Present analyses demonstrate that 3-HPC may exhibit separate impacts on the nervous structure, arguably contributing to some of the unanticipated reactions re